Journal Article Review Epublish
PubMed: 40271049 DOI: 10.1016/j.jot.2025.03.011
Ferroptosis-mediated immune responses in osteoporosis.
J Orthop Translat 52:116-125
Authors: Wang Xiao, Wang Yike, Liu Gongwen, Xu Youjia
Affiliations
- Department of Orthopaedics, The Second Affiliated Hospital of Soochow University, Suzhou, China.
- Department of Orthopaedics, Suzhou TCM Hospital Affiliated to Nanjing University of Chinese Medicine, Suzhou, China.
Abstract
Osteoporosis is a common systemic metabolic disease, characterized by decreased bone mass and susceptibility to fragility fractures, often associated with aging, menopause, genetics, and immunity. Ferroptosis plays an underestimated yet crucial role in the further impact of immune function changes on osteoporosis. Cell ferroptosis can induce alterations in immune function, subsequently influencing bone metabolism. In this context, this review summarizes several mechanisms of ferroptosis and introduces the latest insights on how ferroptosis regulates immune responses, exploring the interactions between ferroptosis and other mechanisms such as oxidative stress, inflammation, etc. This review elucidates potential treatment strategies for osteoporosis, emphasizing the promising potential of ferroptosis as an emerging target in the treatment of osteoporosis. In conclusion, preparations related to ferroptosis exhibit substantial clinical promise for enhancing bone mass restoration. The translational potential of this article: This review elucidates a nuanced conversation between the immune system and osteoporosis, with ferroptosis serving as the connecting link. These findings underscore the potential of ferroptosis inhibition as a therapeutic strategy for osteoporosis.
MeSH
Ferroptosis, Osteoporosis, Immunity, Therapeutics
Cited by
- "Multidisciplinary synergy driving innovation in orthopaedic translational medicine". J Orthop Translat, 2025